Somewhat Favorable Media Coverage Somewhat Unlikely to Affect Fresenius Medical Care (FMS) Stock Price
Media coverage about Fresenius Medical Care (NYSE:FMS) has been trending somewhat positive recently, Accern Sentiment reports. The research firm rates the sentiment of media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Fresenius Medical Care earned a media sentiment score of 0.19 on Accern’s scale. Accern also gave news coverage about the company an impact score of 46.467851877329 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
Here are some of the media stories that may have impacted Accern’s rankings:
- Fresenius Medical Earns RS Rating Upgrade (finance.yahoo.com)
- Fresenius Medical Care achieves a milestone in expanding its Asian operations (marketwired.com)
- Saudi Arabia Medical Devices Market 2017 Amplifies Impressively; CAGR of ~9.5% by 2023 (emailwire.com)
- Robust Sales Growth Keep Fresenius Medical Care (FMS) a Buy (investorplace.com)
- Fresenius Medical Care North America Sets Record in Surpassing its Kidney Walk Fundraising Goal (finance.yahoo.com)
Fresenius Medical Care (NYSE FMS) traded down $0.23 during mid-day trading on Tuesday, hitting $50.72. 96,420 shares of the stock traded hands, compared to its average volume of 180,037. The firm has a market capitalization of $31,420.00, a price-to-earnings ratio of 22.31, a PEG ratio of 2.24 and a beta of 0.45. Fresenius Medical Care has a twelve month low of $39.46 and a twelve month high of $51.54. The company has a quick ratio of 0.98, a current ratio of 1.22 and a debt-to-equity ratio of 0.55.
Fresenius Medical Care Company Profile
Fresenius Medical Care AG & Co KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment.
Receive News & Stock Ratings for Fresenius Medical Care Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care Corporation and related stocks with our FREE daily email newsletter.